Core Viewpoint - The AI Fund Penghua Pension Industry Stock (000854) reported a profit of 84.99 million yuan for the first half of 2025, with a weighted average profit per fund share of 0.4241 yuan. The fund's net value growth rate was 21.38%, and the fund size reached 464 million yuan by the end of the reporting period [3][36]. Fund Performance - As of September 2, the fund's unit net value was 2.983 yuan. The fund manager, Jin Xiaofei, has managed six funds, all of which have shown positive returns over the past year. The highest growth rate among these funds was 112.81% for Penghua Medical Technology Stock A, while the lowest was 42.01% for Penghua Innovative Medicine Mixed A [3]. - The fund's performance over different time frames includes a three-month net value growth rate of 23.11% (ranked 66 out of 167), a six-month growth rate of 38.49% (ranked 14 out of 167), a one-year growth rate of 56.67% (ranked 49 out of 166), and a three-year growth rate of -2.20% (ranked 113 out of 160) [6]. Valuation Metrics - As of June 30, 2025, the fund's weighted average price-to-earnings (P/E) ratio was approximately -1038.47 times, compared to the industry average of 23.39 times. The weighted average price-to-book (P/B) ratio was about 4.71 times, while the industry average was 2.44 times. The weighted average price-to-sales (P/S) ratio was 9.47 times, against an industry average of 2.1 times [13]. Growth Metrics - For the first half of 2025, the fund's weighted average revenue growth rate was 0.11%, and the weighted average net profit growth rate was -0.83%. The weighted annualized return on equity was 0% [22]. Risk and Return Metrics - The fund's Sharpe ratio over the past three years was -0.2327, ranking 133 out of 159 comparable funds. The maximum drawdown over the same period was 44.66%, with the largest single-quarter drawdown occurring in Q1 2021 at 25.48% [30][32]. - The fund's average stock position over the past three years was 84.94%, compared to the industry average of 88.01% [35]. Fundholder Composition - As of June 30, 2025, the fund had 56,200 holders, collectively holding 193 million shares. Management and staff held 133,800 shares (0.07%), institutional investors held 0.02%, and individual investors accounted for 99.98% of the holdings [40]. Trading Activity - The fund's turnover rate for the last six months was approximately 64.05%, which has consistently been below the industry average [43]. Top Holdings - As of June 30, 2025, the fund's top ten holdings included companies such as Baijia Shenzhou, Heng Rui Pharmaceutical, Dize Pharmaceutical, Shouyao Holdings, Aosaikang, Ganli Pharmaceutical, Nuocheng Jianhua, Zhixiang Jintai, Bai'ao Tai, and Kexing Pharmaceutical [46].

截至7月17日，鹏华养老产业股票近三个月复权单位净值增长率为23.34%，位于同类可比基金12/167；近半年复权单位净值增长率为38.93%，位于同类可比 基金2/167；近一年复权单位净值增长率为35.39%，位于同类可比基金30/166；近三年复权单位净值增长率为-14.91%，位于同类可比基金100/159。 通过所选区间该基金净值增长率分位图，可以观察该基金与同类基金业绩比较情况。图为坐标原点到区间内某时点的净值增长率在同类基金中的分位数。 AI基金鹏华养老产业股票（000854）披露2025年二季报，第二季度基金利润4195.51万元，加权平均基金份额本期利润0.2136元。报告期内，基金净值增长 率为9.71%，截至二季度末，基金规模为4.64亿元。 该基金属于标准股票型基金。截至7月17日，单位净值为2.716元。基金经理是金笑非，目前管理6只基金近一年均为正收益。其中，截至7月17日，鹏华医药 科技股票A近一年复权单位净值增长率最高，达88.79%；鹏华养老产业股票最低，为35.39%。 基金管理人在二季报中表示，我们从 2022 年底翻多创新药后，一直重仓此方向，中间波动较多，但整体上仓位 ...